✦ LIBER ✦
Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) during imatinib treatment
✍ Scribed by Scheuring, U J; Pfeifer, H; Wassmann, B; Brück, P; Gehrke, B; Petershofen, E K; Gschaidmeier, H; Hoelzer, D; Ottmann, O G
- Book ID
- 110055592
- Publisher
- Nature Publishing Group
- Year
- 2003
- Tongue
- English
- Weight
- 134 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.